MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales Revenue Gross
$88,085M
(5.28%↑ Y/Y)
Net Product Sales
$46,756M
(-0.05%↓ Y/Y)
Alliance And Other
Revenues
$1,438M
(-5.52%↓ Y/Y)
Gross to net
adjustments
-$41,329M
(-12.02%↓ Y/Y)
Total revenues
$48,194M
(-0.22%↓ Y/Y)
Medicaidand
Medicarerebates
-$18,010M
(-8.82%↓ Y/Y)
Chargebacksandcashdiscounts
-$14,067M
(-22.22%↓ Y/Y)
Other Rebates Returns
Discounts And Adjustments
-$9,253M
(-4.77%↓ Y/Y)
Earnings/(loss) before income
taxes
$9,328M
(211.33%↑ Y/Y)
Total expenses
$38,866M
(-31.43%↓ Y/Y)
Net
earnings/(loss)
$7,055M
(178.98%↑ Y/Y)
Income tax provision
$2,272M
(310.11%↑ Y/Y)
Cost of products sold
$13,936M
(-0.23%↓ Y/Y)
Research and development
$9,951M
(-10.83%↓ Y/Y)
Selling, general and
administrative
$7,267M
(-13.63%↓ Y/Y)
Acquired iprd
$3,721M
(-72.18%↓ Y/Y)
Amortization of acquired
intangible assets
$3,317M
(-62.61%↓ Y/Y)
Other
(income)/expense, net
-$674M
(24.52%↑ Y/Y)
Royalty income -
divestitures (note 4)
$1,129M
(2.26%↑ Y/Y)
Royalty and licensing
income (note 4)
$1,093M
(48.51%↑ Y/Y)
Investment income
$586M
(22.59%↑ Y/Y)
Equity investment
(gains)/losses, net (note 9)
$280M
(1650.00%↑ Y/Y)
Net
earnings/(loss) attributable to...
$7,054M
(178.83%↑ Y/Y)
Noncontrolling interest
$2M
(-86.67%↓ Y/Y)
Interest expense
$1,891M
(-2.88%↓ Y/Y)
Provision for
restructuring (note 6)
$563M
(-11.34%↓ Y/Y)
Litigation and other
settlements
-$434M
(-416.67%↓ Y/Y)
Loss on debt
redemption (note 10)
-$356M
Contingent consideration
(note 9)
$351M
Integration expenses (note
6)
$147M
(-48.24%↓ Y/Y)
Other
-$11M
(93.33%↑ Y/Y)
Acquisition expense
$9M
(-82.00%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BRISTOL MYERS SQUIBB CO (CELG-RI)
BRISTOL MYERS SQUIBB CO (CELG-RI)